NYSE · Pharmaceutical Preparations
Merck & Co., Inc.MRK
Merck & Co., Inc. (MRK) is listed on NYSE; the SEC classifies it under "Pharmaceutical Preparations". For fiscal 2025 (ended Dec 31, 2025) it reported revenue of $65.01B, up 1.3% from fiscal 2024. Net income was $18.25B, a net margin of 28.1%. At fiscal year end it had total assets of $136.87B and stockholders' equity of $52.61B (38.4% of assets).
Company profile
- Ticker
- MRK
- Exchange
- NYSE
- Industry (SIC)
- Pharmaceutical PreparationsSIC 2834
- Fiscal year end
- December 31
- Headquarters
- Rahway, NJ
- Incorporated in
- NJ
- SEC filer category
- Large accelerated filer
- SEC CIK
- 310158
Key financials (annual, 10-K)
| Key financials (annual, 10-K) | FY2025ended Dec 31, 2025 | FY2024ended Dec 31, 2024 | FY2023ended Dec 31, 2023 | FY2022ended Dec 31, 2022 | FY2021ended Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $65.01B | $64.17B | $60.12B | $59.28B | $48.7B |
| Revenue growth (YoY) | +1.31% | +6.74% | +1.40% | +21.72% | — |
| Net income | $18.25B | $17.12B | $365M | $14.52B | $13.05B |
| Net income growth (YoY) | +6.64% | +4,589.59% | -97.49% | +11.27% | — |
| Net margin | 28.1% | 26.7% | 0.6% | 24.5% | 26.8% |
| Diluted EPS | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 |
| Total assets | $136.87B | $117.11B | $106.68B | $109.16B | $105.69B |
| Total liabilities | — | — | — | — | — |
| Stockholders' equity | $52.61B | $46.31B | $37.58B | $45.99B | $38.18B |
| Equity ratio (equity / assets) | 38.4% | 39.5% | 35.2% | 42.1% | 36.1% |
| Cash and cash equivalents | $14.57B | $13.24B | $6.84B | $12.69B | $8.1B |
| Shares outstanding | 2.47B | 2.53B | 2.53B | 2.54B | 2.53B |
Values as reported in each fiscal year's Form 10-K (XBRL data on SEC EDGAR); growth and ratios are computed from those values. Revenue is the total revenue figure the company tagged (omitted when the only figure tagged is evidently partial, e.g. below net income); growth is only shown between consecutive ~12-month fiscal years reported with the same revenue measure. Per-share figures and share counts are as reported and not adjusted for later stock splits. — = not reported.
Recent SEC filings
All filings on SEC EDGAR- 8-KCurrent reportFiled: Oct 29, 2026
- 8-KCurrent reportPeriod: Oct 9, 2026Filed: Oct 13, 2026
- 10-QQuarterly reportPeriod: Jun 30, 2026Filed: Aug 7, 2026
- 8-KCurrent reportFiled: Aug 4, 2026
- 8-KCurrent reportPeriod: May 26, 2026Filed: May 28, 2026
- 8-KCurrent reportFiled: May 22, 2026
- 10-QQuarterly reportPeriod: Mar 31, 2026Filed: May 4, 2026
- 8-KCurrent reportFiled: Apr 30, 2026
- DEF 14AProxy statementPeriod: May 26, 2026Filed: Apr 8, 2026
- 10-KAnnual reportPeriod: Dec 31, 2025Filed: Feb 24, 2026
Frequently asked questions
What does Merck & Co., Inc. do?
The SEC classifies Merck & Co., Inc. under Standard Industrial Classification (SIC) code 2834, "Pharmaceutical Preparations". It is headquartered in Rahway, NJ. It is incorporated in NJ. In fiscal 2025 it reported revenue of $65.01B and net income of $18.25B in its annual 10-K report.
What was Merck & Co., Inc.'s revenue in 2025?
Merck & Co., Inc. reported revenue of $65.01B for fiscal 2025, which ended Dec 31, 2025, up 1.3% from $64.17B in fiscal 2024, according to its annual 10-K report filed with the SEC on Feb 24, 2026.
What was Merck & Co., Inc.'s net income in 2025?
Merck & Co., Inc. reported net income of $18.25B for fiscal 2025, a net margin of 28.1% of revenue.
Where is Merck & Co., Inc. listed?
According to the SEC, Merck & Co., Inc.'s ticker MRK is listed on NYSE.
When does Merck & Co., Inc.'s fiscal year end?
According to the SEC, Merck & Co., Inc.'s fiscal year ends on December 31; its latest reported fiscal year (2025) ended Dec 31, 2025.
Companies in the same industry
All US stocksSource: SEC EDGAR · Last updated:
Ver en españolNot investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.